Literature DB >> 23399364

Recommendations for managing the donation of haematopoietic stem cells from related and unrelated donors for allogeneic transplantation.

Giuseppe Aprili1, Alberto Bosi, Letizia Lombardini, Simonetta Pupella, Aurora Vassanelli.   

Abstract

Mesh：

Year:  2013        PMID： 23399364      PMCID： PMC3626483          DOI： 10.2450/2012.0083-12

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  43 in total

1.  G-CSF-induced spleen size changes in peripheral blood progenitor cell donors.

Authors:  David Stroncek; Thomas Shawker; Dean Follmann; Susan F Leitman
Journal:  Transfusion       Date:  2003-05       Impact factor: 3.157

2.  Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association.

Authors:  Michael Boo; Suzanna M van Walraven; Jeremy Chapman; Brian Lindberg; Alexander H Schmidt; Bronwen E Shaw; Galen E Switzer; Edward Yang; Torstein Egeland
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

3.  Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation.

Authors:  A M Gianni; S Siena; M Bregni; C Tarella; A C Stern; A Pileri; G Bonadonna
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

4.  Antigen CD34+ marrow cells engraft lethally irradiated baboons.

Authors:  R J Berenson; R G Andrews; W I Bensinger; D Kalamasz; G Knitter; C D Buckner; I D Bernstein
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  S Siena; M Bregni; B Brando; F Ravagnani; G Bonadonna; A M Gianni
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

6.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

7.  Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.

Authors:  B E Shaw; L Ball; M Beksac; M Bengtsson; D Confer; S Diler; M Fechter; H Greinix; M Koh; S Lee; G Nicoloso-De-Faveri; J Philippe; S Pollichieni; M Pulsipher; A Schmidt; E Yang; A-M van Walraven
Journal:  Bone Marrow Transplant       Date:  2010-02-22       Impact factor: 5.483

8.  Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.

Authors:  L B To; M M Roberts; D N Haylock; P G Dyson; A L Branford; D Thorp; J Q Ho; G W Dart; N Horvath; M L Davy
Journal:  Bone Marrow Transplant       Date:  1992-04       Impact factor: 5.483

Review 9.  Peripheral blood stem cell autografting.

Authors:  A J Bell; T J Hamblin; D G Oscier
Journal:  Hematol Oncol       Date:  1987 Jan-Mar       Impact factor: 5.271

10.  Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.

Authors:  P Topcuoglu; M Arat; K Dalva; M Ozcan
Journal:  Bone Marrow Transplant       Date:  2004-01       Impact factor: 5.483
View more
  2 in total

1.  Indications and organisational methods for autologous blood transfusion procedures in Italy: results of a national survey.

Authors:  Liviana Catalano; Alessandra Campolongo; Maurizio Caponera; Alessandra Berzuini; Andrea Bontadini; Giuseppe Furlò; Patrizio Pasqualetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

Review 2.  Discussing and managing hematologic germ line variants.

Authors:  Wendy Kohlmann; Joshua D Schiffman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.